2010
DOI: 10.1038/onc.2010.354
|View full text |Cite
|
Sign up to set email alerts
|

The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program

Abstract: Microtubule-interfering cancer drugs such as paclitaxel (PTX) often cause chemoresistance and severe side effects, including neurotoxicity. To explore potentially novel antineoplastic molecular targets, we investigated the cellular response of breast carcinoma cells to short hairpin(sh)RNA-mediated depletion of the centrosomal protein transforming acidic coiled coil (TACC) 3, an Aurora A kinase target expressed during mitosis. Unlike PTX, knockdown of TACC3 did not trigger a cell death response, but instead re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
48
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(52 citation statements)
references
References 55 publications
4
48
0
Order By: Relevance
“…TACC3 deficiency leads to severe growth retardation and embryonic lethality (38,40). This is in line with the anti-proliferative and cell cycle arrest/senescenceinducing impact of shRNA-mediated gene silencing of TACC3 (41,42). Moreover, it could be shown that TACC3 depletion sensitizes cells to the apoptotic and senescence-inducing effects of mitotic spindle poisons.…”
Section: Discussionmentioning
confidence: 55%
See 1 more Smart Citation
“…TACC3 deficiency leads to severe growth retardation and embryonic lethality (38,40). This is in line with the anti-proliferative and cell cycle arrest/senescenceinducing impact of shRNA-mediated gene silencing of TACC3 (41,42). Moreover, it could be shown that TACC3 depletion sensitizes cells to the apoptotic and senescence-inducing effects of mitotic spindle poisons.…”
Section: Discussionmentioning
confidence: 55%
“…During the cell cycle TACC3 expression increases strongly in the G 2 /M phase (38) followed by Cdh1-dependent degradation of TACC3 during mitotic exit (39). TACC3 deficiency leads to growth retardation and embryonic lethality (38,40), in line with the anti-proliferative impact of shRNA mediated gene silencing of TACC3 (41,42).…”
mentioning
confidence: 87%
“…TACC3, which is reactivated in a wide range of tumor types, is the best-characterized member of this cohort, with a demonstrated role in embryonic development and differentiation. However, with the exception of TACC3 and ACRBP, no tumorigenic role has been identified for these testis genes (2,9,15,19,33,(35)(36)(37). Given the phenotypic collaboration observed with the mitotic spindle poison paclitaxel, we first sought to determine if individual depletion of members of this cohort (FMR1NB, MAGEA5, NXF2, FSIP1, STARD6, and TACC3) leads to chromosome segregation defects in the presence of low-dose paclitaxel.…”
Section: Resultsmentioning
confidence: 99%
“…Yim et al identified TACC3 as a possible direct target of anti-microtubule drugs such as paclitaxel in cervical carcinoma cells (37). Subsequent studies have demonstrated that paclitaxel induces strong polyploidy and apoptosis in TACC3-depleted murine fibroblast cells and that the downregulation of TACC3 enhances paclitaxel chemosensitivity in breast carcinoma cells (38,39). However, if the expression of TACC3 in tumor tissue by immunohistochemical analysis correlates with the sensitivity to anti-microtubule drugs has not been reported yet.…”
Section: Univariate Analysismentioning
confidence: 99%